New Results On Treatment Of Gynaecological Cancers - European Cancer Congress 2023

New Results on Treatment of Gynaecological Cancers - European Cancer Congress (ESMO) 2023

Updates in gynecological cancers at ESMO 2023

Highlights in gynecological cancers at ESMO 2023

ESMO Gynaecological Cancers Congress: key developments in ovarian cancer

ASCO 2023 Expert Report on novelties in the treatment of gynaecological malignancies, by P. Harter

European Society for Medical Oncology (ESMO)

New Results on Treatment of Early Breast Cancer - European Cancer Congress (ESMO) 2023

New Results on Treatment of Metastatic Breast Cancer - European Cancer Congress (ESMO) 2023

Tisotumab Vedotin for Metastatic Cervical Cancer: Results From ESMO 2023 With Brian Slomovitz, MD

Oncology Data Advisor

Breakthroughs in urothelial cancer treatment at ESMO 2023

Management of patients with gynecological cancer

Highlights on amivantamab after progression on osimertinib in EGFR-mutated NSCLC: MARIPOSA-2

European Society for Medical Oncology (ESMO)

INTERLACE: induction chemotherapy + CRT as new SOC in locally advanced cervical cancer

Expert report on survival data from pivotal trials with PARP inhibitors for BRCA-mut. Ovarian Cancer

European Society for Medical Oncology (ESMO)

Updates in the treatment of genitourinary cancers

Advances in colorectal cancer therapies at ESMO 2023

Future directions of the RCT assessing follow-up management of gynecological cancer

Highlights on Lu-PSMA-617 in taxane-naive patients with mCRPC: The PSMAfore study

European Society for Medical Oncology (ESMO)

#ESMO21 Highlights on pembro + chemo in 1st-line metastatic cervical cancer: The KEYNOTE-826 study

European Society for Medical Oncology (ESMO)

Ella T. Grasso Memorial Gynecologic Oncology Conference

Yale Cancer Center

ESMO Immuno-Oncology Congress 2023: Michele Maio & Aurélien Marabelle on why you should register

European Society for Medical Oncology (ESMO)